Interest of the Dosage of Adalimumab Serum Levels in Crohn's Disease Patients for Prevention of Postoperative Recurrence
Clinical trial NCT04200547 · TERMINATED
Trial details
- NCT number
- NCT04200547
- Sponsor
- University Hospital, Montpellier
- Status
- TERMINATED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-29
- Primary completion
- 2024-06-29
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.